Article
Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
Anticancer research - 1 Nov 2014
Mishra Mukti N, Mishra Mukthi N, Vangara Kiran K, Palakurthi Srinath
Abstract excerpt
BACKGROUND: The major factor limiting the efficacy of breast cancer chemotherapy is multidrug resistance due to overexpression of the breast cancer resistance protein ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2). We hypothesized that conversion of camptothecin-11 (CPT-11) to its highly cytotoxic metabolite SN-38 by a mutant human carboxyl esterase (hCE1m6) specifically in cancer cells and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
